Benneker patent opposition analysis

The comprehensive analysis of Benneker opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Benneker

Patent NumberTitleApplicantOpposition DateOpposition Company
A Rapamycin Derivative For Treating Lung CancerNOVARTISAug 27, 2019SYNTHON
Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICADec 23, 2016SYNTHON
Methods Of Using Sustained Release Aminopyridine CompositionsACORDA THERAPEUTICSMar 7, 2012SYNTHON

Top companies who are the clients of Benneker

CompanyTotal
SYNTHON3